Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' DEFICIT (Details Narrative)

v2.4.0.8
STOCKHOLDERS' DEFICIT (Details Narrative) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Nov. 08, 2013
Nov. 30, 2012
Feb. 21, 2012
Feb. 07, 2012
Dec. 31, 2011
Jun. 30, 2011
May 23, 2011
May 02, 2011
Equity [Abstract]                    
Authorized capital, common stock 750,000,000                  
Authorized capital, common stock par value $ 0.0001                  
Authorized capital, preferred stock 10,000,000                  
Authorized capital, preferred stock par value $ 0.0001                  
Preferred stock designated as Series A 3,000,000                  
Preferred stock designated as Series D 1,000,000                  
Authorized Series D Preferred Stock       4,000,000            
Conversion of Series D Preferred Stock into the Company's common stock       5            
Series D Preferred Stock affiliated with more than the outstanding shares of common stock       9.99%            
Issuance of Series D Preferred Stock       1,000,000            
Issuance of Series D Preferred Stock Purchase Price       $ 50,000            
Assigned total principal amount of convertible debentures               125,000    
Purchase price of Assigned Securities               125,000    
Issuance of common stock in connection with the conversion of the Assigned Debenture               5,000,000    
Issuance of common stock to Daniel Bleak                   10,000,000
Five year option to purchase shares of Common Stock                   30,000,000
Exercise price, per share, for common stock                   $ 0.05
Mineral cost                   500,000
Shares of common stock sold                 11,000,000  
Purchase price of common stock sold, per share                 $ 0.05  
Aggregate purchase price of common stock sold                 550,000  
Total amount of convertible debentures converted into common stock           55,000 325,000      
Issuance of common stock in connection with the conversion of convertible debentures           2,200,000 13,000,000      
Issuance of common stock to consultant for consulting and investor relations services rendered             1,000,000      
Valued common shares at the fair market value, per share         $ 0.14   $ 0.13      
Valued common shares at the fair market value         3,500,000   130,000      
Stock based consulting             130,000      
Purchased shares of common stock to Mr. Bleak         30,000,000          
Restricted shares of common stock granted to Mr. Bleak as compensation for continued services         25,000,000          
Cancelled shares     34,500,000              
Adjustment to additional paid in capital     3,450              
Conversion price convertible notes     243,382              
Conversion price per share     $ 0.03              
Common stock issued for conversion     8,112,733              
Interest expense for conversion     68,147              
Option to purchase shares of Common Stock                   30,000,000
Option to purchase shares of Common Stock, per option                   $ 0.05
Option to purchase shares of Common Stock, total amount                   1,494,596
Volatility rate                   25900.00%
Risk-free interest rate                   1.96%
Stock-based compensation expense related to stock options $ 0 $ 41,516